Prevalence of obesity, hyperlipemia and insulin resistance in children with suprasellar brain tumors.
Weight gain is a common sequela of suprasellar tumors, referred to as hypothalamic obesity. We undertook an evaluation of obesity and metabolic aberrations among patients treated at our institute. During the 12 mo from Apr. 2005, 23 patients (10 males and 13 females) with remitted suprasellar tumors attended our clinic: 10 patients with craniopharyngioma, 7 with germinoma, 4 with optic nerve glioma and others. Of these, 12 patients (52%) were found to have obesity on the basis of percent overweight and/or percent body fat. Elevated cholesterol and/or triglyceride (TG) was found in 9 patients (39%), and insulin resistance was suspected in 7 patients (30%). Three patients exhibited strikingly elevated postprandial TG levels. All 6 patients with the growth without GH phenomenon had at least one metabolic aberration. In conclusion, the prevalence of hypothalamic obesity was nearly half in our series, and hyperlipemia and insulin resistance were also frequently found. The increased risk for metabolic aberration in growth without GH patients was suggested.
Department of Endocrinology and Metabolism, Clinical Research Institute, Kanagawa Children's Medical Center, Yokohama, Japan.
Masanori
M
Adachi
Department of Endocrinology and Metabolism, Clinical Research Institute, Kanagawa Children's Medical Center, Yokohama, Japan.
Takayoshi
T
Tsuchiya
Department of Endocrinology and Metabolism, Clinical Research Institute, Kanagawa Children's Medical Center, Yokohama, Japan.
Koji
K
Muroya
Department of Endocrinology and Metabolism, Clinical Research Institute, Kanagawa Children's Medical Center, Yokohama, Japan.
Yumi
Y
Asakura
Department of Neurosurgery, Kanagawa Children's Medical Center, Yokohama, Japan.
Ken-Ichi
K
Sekido
Department of Neurosurgery, Kanagawa Children's Medical Center, Yokohama, Japan.
Hironobu
H
Sato
craniopharyngioma; growth without GH; hypertriglyceridemia; hypothalamic obesity; metabolic syndrome